Use of MIB-1 (Ki-67) Immunoreactivity in Differentiating Grade II and Grade III Gliomas

• 1 August 1997
• journal article
• research article
• Published by Oxford University Press (OUP) in Journal of Neuropathology and Experimental Neurology
• Vol. 56  (8) , 857-865
• https://doi.org/10.1097/00005072-199708000-00003

Abstract

Keywords

• GLIOMA
• KI-67 ANTIGEN
• WORLD HEALTH ORGANIZATION
• NEOPLASMS
• NEOPLASM GRADING
• MONOCLONAL ANTIBODIES
• GENDER
• PROGNOSTIC FACTORS
• COX PROPORTIONAL HAZARDS MODELS
• GRADING SYSTEM
• UNIVARIATE ANALYSIS
• BRAIN